An interventional study of Ejaculation Preserving Photoselective Vaporization and Ejaculation Preserving Plasma Kinetic Vaporization in Ejaculation Abnormal, BPH With Urinary Obstruction and Prostatic Hyperplasia, sponsored by Mansoura University. Status unknown at 1 site in Egypt. Open to male participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-07-17.
Sponsored by Mansoura University · Not applicable, Interventional, and Treatment
To Evaluate and compare the outcome and coast of ejaculation sparing management of BPH using 3 different techniques: PVP, PKVP and TURP. Ejaculation sparing TURP group is considered the standard control group. Evaluation will be carried out through a prospective randomized powered trial
827 studies on the registry are indexed under Prostatic Hyperplasia; 179 are open to participants now.
This study's planned enrollment of 84 is close to the median of 92 across 626 interventional studies indexed under Prostatic Hyperplasia.
Browse Prostatic Hyperplasia studies →Mansoura University is the lead sponsor of 1,119 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age >50 years 2. Prostate volume (measured by TRUS): 30-80 gm 3. International prostate symptom score (IPSS )>15 and quality of life score (QOL)\< 3.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Ejaculation Preserving Photoselective Vaporization
Procedure: Ejaculation Preserving Plasma Kinetic Vaporization
Procedure: Ejaculation Preserving Transurethral Resection Of The Prostate
Ejaculation Preserving Photoselective Vaporization
Ejaculation Preserving Plasma Kinetic Vaporization
Ejaculation Preserving Transurethral Resection Of The Prostate
estimate and compare the ejaculation preservation effect of the 3 techniques (PKVP, PVP and TURP).
assessed by Male Sexual Health Questionnaire (MSHQ)
Time frame: 1 years
change in flow rate
measured by uroflowmetery in ml/sec
Time frame: 1 years
postoperative complication
measured by Clavien-Dindo Classification scale
Time frame: 1 year
change in patients' symptoms.
measured by International Prostate Symptom Score (I-PSS)
Time frame: 1 year
This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.